Free shipping on all orders over $ 500

Plitidepsin

Cat. No. M21600
Plitidepsin Structure
Synonym:

Aplidine

Size Price Availability Quantity
5mg USD 1500  USD1500 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Plitidepsin (Aplidine) is a potent anticancer compound targeting eEF1A2 (KD=80 nM). Plitidepsin has antiviral activity, and the IC90 of inhibiting SARS-CoV-2 is 0.88 nM. Plitidepsin is commonly used in multiple myeloma and advanced cancer research and has potential for COVID-19 research.

Chemical Information
Molecular Weight 1110.34
Formula C57H87N7O15
CAS Number 137219-37-5
Solubility (25°C) DMSO ≥ 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Michail Papapanou, et al. J Pers Med. Plitidepsin: Mechanisms and Clinical Profile of a Promising Antiviral Agent against COVID-19

[2] Kris M White, et al. Science. Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A

[3] No authors listed. Aust Prescr. Plitidepsin for multiple myeloma

[4] Michael Leisch, et al. Future Oncol. Plitidepsin: a potential new treatment for relapsed/refractory multiple myeloma

[5] Sara Alonso-lvarez, et al. Drug Des Devel Ther. Plitidepsin: design, development, and potential place in therapy

Related DNA/RNA Synthesis Products
PR-104

PR-104 is a novel hypoxia-activated DNA cross-linking agent with marked activity against human tumor xenografts, both as monotherapy and combined with radiotherapy and chemotherapy.

D-I03

D-I03 is a selective RAD52 inhibitor with a Kd of 25.8 µM. D-I03 specifically inhibits RAD52-dependent single-strand annealing (SSA) and D-loop formation with IC50s of 5 µM and 8 µM, respectively.

Bractoppin

Bractoppin is a potent and selective inhibitor of phosphopeptide recognition by the human BRCA1 tandem(t) BRCT domain with IC50 of 74 nM. Bractoppin diminishes BRCA1 recruitment to DNA breaks, in turn suppressing damage-induced G2 arrest and assembly of the recombinase, RAD51.

Tofersen

Tofersen (BIIB067) is an antisense oligonucleotide that mediates RNase H-dependent degradation of superoxide dismutase 1 (SOD1) mRNA to reduce SOD1 protein synthesis. Tofersen can be used in amyotrophic lateral sclerosis (ALS) research.

ART812

ART812 is an orally effective DNA polymerase Polθ inhibitor with an IC50 value of 7.6 nM. ART812 had an IC50 value of 240 nM for cell-based microhomologous mediated end-junction (MMEJ).

  Catalog
Abmole Inhibitor Catalog




Keywords: Plitidepsin, Aplidine supplier, DNA/RNA Synthesis, inhibitors, activators

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.